Zinforo

Consideration should be given to official guidance on the appropriate use of antibacterial agents. Organisms that are resistant to ZINFORO® can occur at variable rates between countries and between healthcare facilities within countries. If ZINFORO® is commenced before susceptibility test results are available, then local information on the risk of encountering resistant organisms should be taken into consideration. 

 

Abbreviations: AMR, antimicrobial resistance; MoA, mode of action

Reference: 1. ZINFORO®. Summary of Product Characteristics. 2017

 

PP-ZFO-IRL-0030 .  Date of Preparation: September 2018